Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures

Site Infection Clinical Trial

Official title:

Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06255652
• Other study ID #: Soh-Med-23-09-05MS
• Status: Recruiting
• Start date: October 1, 2023
• Est. completion date: July 31, 2024

Study information

• Verified date: February 2024
• Source: Sohag University
• Contact: yasmeen YT Tharwat, Resident
• Phone: 01289986222
• Email: yassmintharwat[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Oral versus intravenous antimicrobial prophylaxis for the prevention of surgical site infection for elective cesarean section and gynacological procedures

Description:

the aim of the current study is to compare the efficacy of prophylactic intravenous (cephradine) and oral antibiotic (cephradine) for the prevention of surgical site infection in the elective obctetric and gynecological procedures

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1
• Est. completion date: July 31, 2024
• Est. primary completion date: July 31, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Cesarean section Gynaecological procedure Exclusion Criteria Immunocompromised patient -

Related Conditions & MeSH terms

• Site Infection

Intervention

Drug:
• Cephradin
Velosef

Locations

Country	Name	City	State
Egypt	Sohag university hospital	Sohag

Sponsors (2)

Lead Sponsor	Collaborator
Sohag University	Randers Regional Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	proportion of patients with any SSI within 30 days after surgery	July 2024	July 2024